Health & Personal Care
HIGH
FDA DRUG
Camber Ketorolac Tromethamine Injection Recall 2025 for Glass Particulates
Camber Pharmaceuticals recalled Ketorolac Tromethamine Injection, USP, 60 mg/2 mL, 2 mL single-dose vials distributed nationwide in the United States. The recall is due to the presence of glass particulates. Healthcare providers and patients should stop using the product immediately and contact Aspiro Pharma Limited at 1-866-495-1995 for guidance.
Ketorolac Tromethamine
Presence of